CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 4 No. 5
Pages: 1  2  
Next
 

Flaxseed May Interfere With Estrogen Synthesis, Lower Risk of Breast Cancer

May 1, 1995

TORONTO, Canada--Researchers have discovered that a high-fiber grain cultivated since the times of the ancient Egyptians may delay the growth of cancerous tumors. In studies conducted on rats, Lilian Thompson, PhD, of the University of Toronto, found that a component isolated from flaxseed reduced mammary tumor growth by more than 50%.

Presenting her work at the annual meeting of the American Association for Cancer Research, Dr. Thompson said that flaxseed, also known as linseed, helps the body to produce animal lignans--diphenolic, small-molecule compounds that can affect hormone levels and have antioxidant and antitumor effects.

Plant Foods Tested for Lignan

Dr. Thompson and her team tested 66 different high-fiber grains, fruits, and vegetables for plant lignans, or lignan-like compounds, that the body can convert into usable animal lignans. She chose flaxseed because "it contains 75 to 800 times more lignan than any other plant food."

Flaxseed also contains an oil rich in alpha-linolenic acid, which is known to have anticancer effects. To determine the active ingredient that suppresses the growth of mammary tumors, Dr. Thompson fed flaxseed and/or secoisolariciresinol diglycoside (SD), the major animal lignan precursor extracted from flaxseed, to rats 13 weeks after they had been injected with a mammary carcinogen.

Dr. Thompson reported that after just 7 weeks, tumors in the animals that had received either flaxseed and/or the SD lignan grew at less than half the rate of the tumors in the control animals that did not get supplements. She also found that there were fewer and smaller new tumors in the group that received lignan.

"Lignan has characteristics that are similar to estrogen," Dr. Thompson said. She suspects that flaxseed lignan interferes with estrogen, limiting the body's ability to synthesize and reabsorb the hormone. She also surmises that lignan may inhibit the growth of blood vessels in the tumor, thus starving the tumor.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy